Ionis Pharmaceuticals Inc 2025 Sustainability Report
Company: Ionis Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2025
Type: Sustainability Report
Pages: 41
The report highlights Ionis's first two independent launches as a commercial-stage biotechnology company, alongside FDA approval of DAWNZERA and progress for its pipeline. The company reports 1,243 global employees and continued investment in its people and communities. It also completed its inaugural climate risk assessment and reports 50% renewable energy purchased or generated in 2025. Scope 1 and 2 emissions totaled 5,748 metric tons CO2e, while emissions intensity declined from 2023.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.